| CARLAT PUBLISHING

Clinicians need to efficiently respond to patient requests for records and document their considered judgment in decisions about restricting records to patients and families. Read More

ECT in Severe Adolescent Mood Disorders

Electroconvulsive therapy (ECT) remains both controversial and difficult to obtain for children and adolescents. Yet when our young patients have truly severe and life-threatening neuropsychiatric conditions, when medication is not going to cut it, we look to ECT for possible help. This research review offers guidance for use of ECT. Read More

The Effect of Age and Pubertal Stage on Mental Health in Gender-Incongruent Youths

When is the best time to begin gender affirming medical care (GAMC) with respect to addressing the mental health status of children and adolescents with Gender Dysphoric Disorder? Should we begin Hormone Replacement Therapy early or wait until the adolescent is older? This research update will help you grapple with this very public debate. Read More

Note From the Editor-in-Chief

At Carlat we dig deeper: Last fall it was the possibility of suicidality with antidepressants when we see the real data; this winter, it was the lack of clinical relevance of CYP enzyme testing when we use medications carefully; and this spring, beneath the apparent weight of thousands of studies that turn out to be flawed, we found an absence of a definable effect size for the massive $17 billion applied behavioral analysis industry. Read More

Approaches to Autism Intervention

How to respond to the seismic shift in our understanding of effect sizes in autism treatment? With better informed consent: we supplemented our interview with Dr Sandbank with an article by Dr Diane Cullinane on the three main kinds of autism treatment so that you will be prepared to help families know that they have choices. Read More

Effect Size Matters: The Seismic Shift Toward Naturalistic and Developmental Interventions in Autism

Thousands of studies that carry the weight of support for Applied Behavioral Analysis treatment for autism are flawed. See what we learned about effect sizes for this massive 17-billion-dollar industry and learn about why it is so hard to study more functional but meaningful change vs rote but less useful learning. Read More

Viloxazine (Qelbree): A Faster Strattera?

As of April, 2021, we have a brand new non-stimulant medication approved for treatment of ADHD in the US. Are we excited? Does this represent an advance over other efforts to produce effective non-stimulant medications for ADHD, or is it another instance of ‘me too’? What does the supporting research tell us? And what side effects do we need to watch out for? Read and learn. Read More

Pharmacotherapy for Autism Spectrum Disorder

What’s new in psychopharmacological treatment for autism? We interviewed Dr. Matthew Krause on his recent review of seven studies covering the rationale for treatment, target symptoms, the use of antipsychotics, over the counter supplements, and some new ideas in pharmacotherapy for ASD. Read More

Psychiatry Practice Boosters, Fourth Edition (2023)
Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

Child Psychiatry
Addressing Suicidality in Autistic Children and Teens
Autistic kids and teens can become despondent or suicidal. This episode explores the distinction between self-injurious behavior and suicidality in autistic children,...
Listen now